January 07, 2021
CARISMA Therapeutics Completes Series B Funding for $47 Million to Advance Development of Novel CAR-Macrophage Immunotherapies
Media
January 06, 2021
Spruce Biosciences Provides Corporate Update and Outlines Milestones for 2021
January 06, 2021
Strongbridge Biopharma plc Announces Preliminary Fourth Quarter and Full-Year 2020 Financial Results and Provides Corporate Update
January 06, 2021
Targovax grants IOVaxis 3 months extension to the exclusive license option for TG mutant RAS vaccines in Greater China and Singapore
January 05, 2021
Aro Biotherapeutics Announces $88 Million Series A Financing to Advance Development of Centyrin-Targeted Genetic Medicines
December 30, 2020
Orexo announces new US patent for ZUBSOLV®
December 28, 2020
Aprea Therapeutics Announces Results of Primary Endpoint from Phase 3 Trial of Eprenetapopt in TP53 Mutant Myelodysplastic Syndromes (MDS)
December 21, 2020
Oncopeptides enrolls the first patient in the phase 3 LIGHTHOUSE combination study in multiple myeloma
December 21, 2020
Positive results show that C21 can become an important complement to COVID-19 vaccines
December 17, 2020
BONESUPPORT moves to Mid Cap
